Tabata T, Hazama S, Yoshino S, Oka M
Department of Surgery II, Yamaguchi University School of Medicine, Ube, Japan.
Am J Surg. 1999 Mar;177(3):203-8. doi: 10.1016/s0002-9610(99)00004-5.
Two types of helper T cells (Th), which are categorized as Th1 and Th2 on the basis of cytokine production, have been reported. Th1 cells produce interleukin (IL)-2 and interferon (IFN)-gamma, while Th2 cells secrete IL-4, IL-6, and IL-10. We assessed the intracellular cytokine profiles of CD3/CD4 positive lymphocytes (CD4+ T-cells) in peripheral blood in patients with digestive cancers.
Peripheral blood samples were collected from 50 patients with digestive cancers and 35 healthy volunteers. The proportions of CD4+ T-cells producing intracellular cytokines were determined using flow cytometry.
The percentages (mean +/- SD) of CD4+ T-cells producing IL-4, IL-6, and IL-10 in the cancer group (73.9% +/- 13.0%, 73.0% +/- 16.6%, and 58.0% +/- 21.0%, respectively) were significantly higher than in the healthy group (37.4% +/- 12.4%, 37.8% +/- 13.5%, and 34.0% +/- 14.1%, respectively; P <0.01). Proportions of CD4+ T-cells producing IL-4, IL-6, and IL-10 in 10 patients undergoing curative resection had decreased significantly 1 month after surgery (P <0.01). No significant difference was noted between groups in the percentages of CD4+ T-cells producing IFN-gamma.
Th2-dominant status develops in cancer patients. Such lymphocyte evaluations could find applications in diagnosis and therapeutic monitoring of cancer patients.
据报道,基于细胞因子的产生可将辅助性T细胞(Th)分为两种类型,即Th1和Th2。Th1细胞产生白细胞介素(IL)-2和干扰素(IFN)-γ,而Th2细胞分泌IL-4、IL-6和IL-10。我们评估了消化系统癌症患者外周血中CD3/CD4阳性淋巴细胞(CD4+T细胞)的细胞内细胞因子谱。
采集50例消化系统癌症患者和35名健康志愿者的外周血样本。使用流式细胞术测定产生细胞内细胞因子的CD4+T细胞比例。
癌症组中产生IL-4、IL-6和IL-10的CD4+T细胞百分比(平均值±标准差)分别为73.9%±13.0%、73.0%±16.6%和58.0%±21.0%,显著高于健康组(分别为37.4%±12.4%、37.8%±13.5%和34.0%±14.1%;P<0.01)。10例行根治性切除的患者术后1个月产生IL-4、IL-6和IL-10的CD4+T细胞比例显著下降(P<0.01)。两组之间产生IFN-γ的CD4+T细胞百分比无显著差异。
癌症患者呈现Th2优势状态。此类淋巴细胞评估可应用于癌症患者的诊断和治疗监测。